Omega-3 And Alzheimer’S Risk — The Strongest Evidence We Have
Quick Read Omega-3 fatty acids, particularly two types called DHA and EPA found in fish and supplements, appear to play
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Lion’s mane mushroom contains compounds that may encourage the production of nerve growth factor, a protein that helps brain cells survive and connect. This is the scientific basis behind claims it improves memory. Animal studies show consistent promise, and a small number of human trials have found modest improvements in cognitive scores and mood, particularly in older adults, though the gains are real but not dramatic.
However, most human studies are small and short-term. Single doses don’t appear to produce immediate effects, suggesting any benefit builds gradually with regular use over weeks or months. One acute study found no cognitive benefit at all. Different lion’s mane products vary significantly in their active compound content, which likely explains some conflicting results across studies.
Side effects are generally mild when they occur, including occasional stomach discomfort or headaches. The evidence stops short of proving lion’s mane works for brain health, but the mechanistic logic is credible and early human results point in the right direction, particularly for memory and mood in middle-aged and older people.
Verdict: Lion’s mane is a reasonably interesting supplement for cognitive support with emerging human evidence, but results are modest and more large-scale human trials are needed before firm conclusions can be drawn.
Here’s a question worth sitting with: what if one of the most hyped supplements of the last decade actually *does* have something real to offer, just not quite in the way the wellness world is selling it? Lion’s mane mushroom (*Hericium erinaceus*) has accumulated a devoted following, with enthusiasts claiming it sharpens focus, protects against dementia, and supercharges memory. Some of that enthusiasm, it turns out, is grounded in genuinely interesting science. But some of it runs well ahead of the evidence. Out of 1.77 million research papers analysed by Vitacuity, 15 of the most relevant studies on lion’s mane and cognitive function were selected for this piece, and what they reveal is a story that’s more nuanced, more honest, and ultimately more useful than the headline hype suggests.
Lion’s mane contains two families of bioactive compounds that are unique to this mushroom: hericenones (found in the fruiting body) and erinacines (found in the mycelium). Both have attracted significant scientific attention because of their apparent ability to stimulate the production of Nerve Growth Factor (NGF), a protein that plays a critical role in the survival, maintenance, and growth of neurons [2][14].
Think of NGF as a kind of fertiliser for your brain cells. Without adequate NGF, neurons struggle to maintain connections, and those connections are the physical substrate of memory and learning. The theoretical pathway is elegant: lion’s mane compounds cross the blood-brain barrier, stimulate NGF production, and in doing so, support the structural integrity of the brain over time [2][10].
Erinacines in particular, the compounds concentrated in the mycelium, have been shown in laboratory and animal studies to reduce neuroinflammation, inhibit the accumulation of amyloid-beta plaques (one of the hallmarks of Alzheimer’s disease), and promote the regeneration of damaged nerve cells [1][2][10]. The chemistry here is genuinely sophisticated, and it’s why researchers are taking lion’s mane seriously as a candidate for future neuroprotective therapies [1][9].
But here’s the honest catch: most of this mechanistic work has been done in cells and in mice. The jump from “works in a petri dish” to “works in a 55-year-old human brain” is enormous, and that jump is exactly where the current evidence sits in tension with the marketing.
The most meaningful human data comes from a small number of randomised controlled trials (RCTs) and pilot clinical trials. A 2025 systematic review published in *Frontiers in Nutrition*, following PRISMA guidelines and registered on PROSPERO, reviewed five RCTs and three pilot clinical trials assessing cognitive outcomes in participants with and without dementia [3][12].
The headline finding: Mini-Mental State Examination (MMSE) scores, a standard test of cognitive function, showed a combined weighted mean increase of 1.17 points in the lion’s mane intervention group compared to controls [3][12]. That’s a statistically meaningful signal, though not a dramatic transformation. To put it in context, MMSE scores range from 0 to 30, and a 1-point difference is modest, meaningful as a directional signal, but not the cognitive leap some supplement brands imply.
The review also found benefits beyond cognition, including improvements in mood and anxiety symptoms, a consistent thread across multiple studies [3][11][12]. Crucially, side effects were generally mild and uncommon: stomach discomfort, headache, and occasional allergic reactions were noted, but serious adverse events were not [3].
Evidence grade: Promising, some human RCT data exists, but sample sizes across the individual trials are small and study durations are relatively short.
A randomised, double-blind, placebo-controlled pilot study published in *Nutrients* (2023) investigated the effects of 1.8 g of lion’s mane on cognitive function and mood in young adults, both acutely (60 minutes after a single dose) and chronically (after 28 days of supplementation) [13].
The results were intriguing. A single dose appeared to produce measurable improvements in cognitive performance within 60 minutes. After 28 days of daily supplementation, further cognitive and mood benefits were observed compared to placebo [13].
The catch, and it’s important, is that this was explicitly described as a pilot study. Sample sizes were small, and the researchers themselves describe the findings as “tentative.” This is exactly the kind of early-stage human data that warrants excitement tempered by patience. It’s a green light for further investigation, not a confirmation of efficacy [13].
Evidence grade: Promising, a well-designed pilot study with encouraging results, but too small to draw firm conclusions.
Honesty matters here, not all the human studies are positive. A 2025 randomised, placebo-controlled, double-blind crossover study published in *Frontiers in Nutrition* tested an acute dose of a standardised lion’s mane extract and found no significant effect on cognitive performance or mood [4].
This directly contradicts some of the findings from the 2023 pilot study above, and it’s worth understanding why. The likely explanations include differences in the extract used (fruiting body vs. mycelium; standardisation of active compounds), dosage, the specific cognitive tests employed, and the population studied. Lion’s mane’s proposed mechanism, stimulating NGF production, is a slow-burn biological process. NGF doesn’t spike in an hour the way caffeine does. So it’s biologically plausible that acute, single-dose studies may simply be the wrong tool for measuring this particular effect [4][2].
This is a case where conflicting results tell us something useful: lion’s mane is unlikely to be a “take one capsule and feel sharper in an hour” supplement. Its potential may be cumulative and structural rather than immediate and stimulant-like.
Evidence grade: Conflicted, acute studies diverge; chronic supplementation studies are more consistently positive, suggesting mechanism matters.
A second 2023 study, a randomised, double-blind, placebo-controlled crossover trial published in *Nutrients*, tested the effects of a single dose of a Nordic lion’s mane extract (650 mg) alongside guayusa tea extract on cognition [15]. The lion’s mane arm alone did not produce significant improvements in cognitive performance compared to placebo, whereas the guayusa (a caffeinated plant) did show effects [15].
Again, this is consistent with the picture emerging: lion’s mane does not appear to act like a cognitive stimulant in the short term. Its value, if real, is likely to be found over weeks and months of consistent use, not in the hour after swallowing a capsule [15][4].
Evidence grade: Promising/Conflicted, acute single-dose studies are underwhelming; the more interesting question is chronic use.
Several well-designed animal studies have added useful texture to the human picture, while also revealing that lion’s mane’s cognitive benefits may be more selective than assumed.
A 2018 study published in the *International Journal of Medicinal Mushrooms* found that dietary supplementation with lion’s mane in wild-type mice over two months improved recognition memory but had no effect on spatial memory [6]. This is a nuanced and important finding. The researchers suggest that lion’s mane may preferentially support perirhinal cortex function (involved in familiarity-based recognition) rather than hippocampal function (involved in spatial navigation and relational memory) [6].
A 2023 mouse study published in *Frontiers* compared lion’s mane against two other medicinal mushrooms and found that only lion’s mane-supplemented animals displayed reliable long-term memory improvements on an object novelty recognition task [7]. Anxiety-like behaviour was not significantly affected in this study [7].
A 2022 study in mice modelling Alzheimer’s-related tau pathology found that lion’s mane supplementation over 4.5 months produced significant anxiolytic (anxiety-reducing) effects but did not improve spatial memory in these disease-model animals [8].
Taken together, the animal literature points toward lion’s mane having a genuine but selective cognitive profile, with recognition memory and anxiety as the most consistent targets, and spatial memory as a less reliable outcome [6][7][8].
Evidence grade: Early stage to Promising, consistent animal findings, but human replication is needed at scale.
Two 2025 narrative reviews and mechanistic analyses highlight lion’s mane as a legitimate candidate for future Alzheimer’s disease research, particularly given the near-total failure of current pharmaceutical approaches to slow neurodegeneration [1][9]. The reviews note that current Alzheimer’s medications offer only symptomatic relief with limited efficacy, and that lion’s mane’s multi-target approach (NGF stimulation, anti-inflammatory activity, amyloid-beta reduction in animal models) makes it scientifically interesting as a complementary or preventative strategy [1][2][9][10].
A 2024 systematic review of 34 human studies examining mushrooms and neurocognition found that dietary patterns including mushrooms were associated with cognitive and mood benefits across epidemiological studies, though intervention studies (where people were actually given lion’s mane) produced mixed results [11]. The review calls for larger, longer human trials with more sensitive cognitive testing methods [11].
Evidence grade: Early stage to Promising, mechanistically compelling, epidemiologically suggestive, but large-scale human RCTs in Alzheimer’s populations are still needed.
Let’s be straightforward about the gaps, because they’re significant.
The human trial data is thin. Most of the studies that make it into systematic reviews involve small samples and short durations. A MMSE improvement of 1.17 points [3][12] is a signal, not a verdict. We need larger, longer trials, ideally in well-defined populations, to understand who benefits most, at what dose, and over what timeframe.
Standardisation is a real problem. Lion’s mane products vary enormously. Some are made from the fruiting body, some from the mycelium, and the concentration of active compounds (erinacines, hericenones) differs dramatically between products and manufacturers. This almost certainly explains some of the conflicting results across studies [4][13][15]. When one study finds an effect and another doesn’t, it may be that they’re not really testing the same thing.
We don’t know the optimal dose or duration. The studies reviewed use doses ranging from 650 mg to 1.8 g, with supplementation periods from acute single doses to 4.5 months [4][6][8][13][15]. No head-to-head dose-response trial in humans has established what “enough” looks like.
The Alzheimer’s research is almost entirely preclinical. The mechanistic story, NGF stimulation, amyloid-beta reduction, has been built largely in cells and mice [1][2][5][9][10]. The gap between a promising animal model and a human clinical outcome is where many seemingly brilliant interventions have failed.
We don’t know whether benefits persist long-term. The longest human study reviewed here runs to 28 days [13]. Whether cognitive benefits accumulate, plateau, or require continuous supplementation is unknown.
Here’s what a sensible, well-informed person should actually do with this information.
Lion’s mane is not the miraculous brain pill that some corners of the wellness world would have you believe. But it’s also not snake oil. The mechanistic science is credible, the animal data is consistent, and the emerging human evidence, while modest and imperfect, points in the right direction, particularly for recognition memory and mood in middle-aged and older adults [3][11][12][13].
The evidence right now sits at promising, enough to take seriously, not enough to treat as proven.
What this means practically:
– If you’re in the 40–65 age bracket and genuinely concerned about cognitive maintenance and healthy ageing, lion’s mane is a reasonable addition to your supplement routine, provided you choose a quality product that specifies its active compound content (look for standardised hericenone or erinacine content) and whether it’s derived from the fruiting body, mycelium, or both. – Don’t expect to feel sharper tomorrow morning. The evidence consistently suggests lion’s mane is not a stimulant, it’s a slow-acting, structurally supportive compound. If it works for you, you’re more likely to notice it over weeks and months than hours [4][13][15]. – It appears to be well-tolerated. Side effects reported across the literature are mild, occasional stomach discomfort, headache, or allergic reactions, and serious adverse events were not reported in the reviewed studies [3]. – The dose used in the most encouraging human pilot study was 1.8 g daily over 28 days [13]. That’s a reasonable reference point when evaluating products. – If you have a known mushroom allergy, exercise appropriate caution [3].
The final honest assessment: lion’s mane is one of the more scientifically interesting supplements in the cognitive health space, not because the evidence is settled, but because the mechanistic rationale is sound and the early human data is directionally positive. Larger, better-powered trials will tell us whether it truly belongs in the front rank of evidence-based cognitive support. For now, it’s a considered, reasonable bet, not a certainty.
[1] Hericium erinaceus: A possible future therapeutic treatment for the prevention and delayed progression of Alzheimer’s disease?, A narrative review. (2025). DOI: 10.1017/S0954422425000058 | https://pubmed.ncbi.nlm.nih.gov/39988819/
[2] Unveiling the role of erinacines in the neuroprotective effects of Hericium erinaceus. (2025). DOI: 10.3389/fphar.2025.1582081 | https://pubmed.ncbi.nlm.nih.gov/40626304/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12230622/
[3] Benefits, side effects, and uses of Hericium erinaceus, systematic review. (2025). DOI: 10.3389/fnut.2025.1641246 | https://pubmed.ncbi.nlm.nih.gov/40959699/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12434001/
[4] Acute effects of a standardised extract of Hericium erinaceus on cognition and mood. (2025). DOI: 10.3389/fnut.2025.1405796 | https://pubmed.ncbi.nlm.nih.gov/40276537/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12018234/
[5] Morphology, anticancer and neurological activities of Hericium erinaceus. (2025). DOI: 10.1590/1519-6984.296172 | https://pubmed.ncbi.nlm.nih.gov/41379127/
[6] Dietary Supplementation of Lion’s Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), and Spatial Memory in Wild-Type Mice. (2018). https://pubmed.ncbi.nlm.nih.gov/29953363/
[7] Effects of Dietary Supplementation with In Vitro-Cultivated Arboreal Medicinal Mushrooms on Long-Term Memory and Anxiety-Like Behavior of Male Mice. (2023). https://pubmed.ncbi.nlm.nih.gov/37183918/
[8] Lion’s Mane (Hericium erinaceus) and cognitive and non-cognitive behaviors in tau-pathology Alzheimer’s disease mice. (2022). DOI: 10.3390/bs12070235 | https://pubmed.ncbi.nlm.nih.gov/35877305/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312024/
[9] Hericium erinaceus: A possible future therapeutic treatment for the prevention and delayed progression of Alzheimer’s disease?, A narrative review. (2025). DOI: 10.1017/S0954422425000058 | https://pubmed.ncbi.nlm.nih.gov/39988819/
[10] Unveiling the role of erinacines in the neuroprotective effects of Hericium erinaceus. (2025). DOI: 10.3389/fphar.2025.1582081 | https://pubmed.ncbi.nlm.nih.gov/40626304/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12230622/
[11] A review of the effects of mushrooms on mood and neurocognitive health across the lifespan. (2024). DOI: 10.1016/j.neubiorev.2024.105548 | https://pubmed.ncbi.nlm.nih.gov/38246232/
[12] Benefits, side effects, and uses of Hericium erinaceus, systematic review. (2025). DOI: 10.3389/fnut.2025.1641246 | https://pubmed.ncbi.nlm.nih.gov/40959699/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12434001/
[13] The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. (2023). DOI: 10.3390/nu15224842 | https://pubmed.ncbi.nlm.nih.gov/38004235/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675414/
[14] Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion’s Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds. (2015). https://pubmed.ncbi.nlm.nih.gov/26244378/
[15] Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion’s Mane Extracts on Cognitive Performance. (2023). DOI: 10.3390/nu15245018 | https://pubmed.ncbi.nlm.nih.gov/38140277/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10745489/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Omega-3 fatty acids, particularly two types called DHA and EPA found in fish and supplements, appear to play
Quick Read Vitamins are organic compounds your body cannot make enough of on its own. They act as molecular tools
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.
